195 related articles for article (PubMed ID: 2619272)
1. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
[TBL] [Abstract][Full Text] [Related]
2. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
Ferrara A; Dos Santos C; Cimbro M; Gialdroni Grassi G
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):535-7. PubMed ID: 9272391
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
Domaracki BE; Evans AM; Venezia RA
Antimicrob Agents Chemother; 2000 May; 44(5):1394-6. PubMed ID: 10770789
[TBL] [Abstract][Full Text] [Related]
4. Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections.
Oliveira AD; d'Azevedo PA; de Sousa LB; Viana-Niero C; Francisco W; Lottenberg C; Martino MD; Höfling-Lima AL
Arq Bras Oftalmol; 2007; 70(4):667-75. PubMed ID: 17906764
[TBL] [Abstract][Full Text] [Related]
5. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Barry AL; Fuchs PC
J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of four species of coagulase-negative staphylococci.
Fass RJ; Helsel VL; Barnishan J; Ayers LW
Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
[TBL] [Abstract][Full Text] [Related]
7. Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.
Patel JA; Pachucki CT; Lentino JR
Antimicrob Agents Chemother; 1993 Feb; 37(2):339-41. PubMed ID: 8452367
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
[TBL] [Abstract][Full Text] [Related]
9. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
[TBL] [Abstract][Full Text] [Related]
11. Comparative synergistic activity of nafcillin, oxacillin, and methicillin in combination with gentamicin against.
Glew RH; Millering RS; Wennersten C
Antimicrob Agents Chemother; 1975 Jun; 7(6):828-32. PubMed ID: 1155924
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
13. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
Joukhadar C; Pillai S; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2010 Feb; 54(2):773-7. PubMed ID: 19933805
[TBL] [Abstract][Full Text] [Related]
14. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Lowy FD; Chang DS; Lash PR
Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
Iluz N; Maor Y; Keller N; Malik Z
Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
[TBL] [Abstract][Full Text] [Related]
16. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
[TBL] [Abstract][Full Text] [Related]
17. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
18. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
[TBL] [Abstract][Full Text] [Related]
19. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
Shalit I; Berger SA; Gorea A; Frimerman H
Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
[TBL] [Abstract][Full Text] [Related]
20. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
